MTOR and endometriosis: Notably, essential information relevant to the use of mTOR inhibitors in endometriosis patients is lacking, including their potential to improve hormone resistance in oestrogen-dependent diseases (e.g. breast and endometrial cancers), their application as immunosuppressants, their role in enhancing fertility in women seeking pregnancy, and effective toxicity management in clinical settings.